Models for Non-Alcoholic Fatty Liver Disease: A Link with Vascular Risk

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|14|4|378-384

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.14, Iss.4, 2008-02, pp. : 378-384

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In Vitro Models for the Study of Non-Alcoholic Fatty Liver Disease

By  

Current Medicinal Chemistry, Vol. 18, Iss. 7, 2011-03 ,pp. : 1079-1084

Bentham Science Publishers

Access to resources Recommend Favorite

Does Non-Alcoholic Fatty Liver Disease (NAFLD) Increase Cardiovascular Risk?

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 8, Iss. 4, 2008-12 ,pp. : 301-307

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging drugs for non-alcoholic fatty liver disease

By Federico Alessandro   Niosi Marco   Vecchio Blanco Camillo Del   Loguercio Carmela  

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 1, 2008-03 ,pp. : 145-158

Informa Healthcare

Access to resources Recommend Favorite

Non-alcoholic fatty liver disease: a massive problem

By Day Christopher P  

Clinical Medicine, Vol. 11, Iss. 2, 2011-04 ,pp. : 176-178

Royal College Of Physicians

Access to resources Recommend Favorite

Non-Alcoholic Fatty Liver Disease in the Metabolic Syndrome

By  

Current Pharmaceutical Design, Vol. 13, Iss. 21, 2007-01 ,pp. : 2193-2198

Bentham Science Publishers

Access to resources Recommend Favorite